What this study is
The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential Tremor, and OCD, but now includes data acquired during all stereotactic brain procedures.
What's being tested
- Stereotactic brain procedures
Intervention · DEVICE
Stereotactic brain procedures
Study details
- Sponsor
- Vanderbilt University Medical Center
- Conditions
- Parkinson's Disease · Obsessive Compulsive Disorder · Dystonia · Essential Tremor · Epilepsy
- Enrolling
- 5,000 people
- Starts
- 2006-08
- Est. completion
- 2027-08
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 6 Years – 90 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients who are recommended for Stereotactic Brain procedures
- Any patient who has agreed to undergo a Stereotactic Brain procedure
- Patients age under 6 -90 years old
You can't join if
- Patients who fail recommendation for Stereotactic Brain procedures
- Patients not consented for Stereotactic Brain procedures
- Patients outside the age range of 6 -90 years old
- Patients or legal guardians not able to provide informed consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openVanderbilt Univeristy
Nashville, Tennessee, United States
- Dario J Englot, MD, Ph.D. · Contact615-322-7417dario.englot@vumc.org
- Wuraola T Adesinasi@vumc.org · Contactwuraola.a.adesinasi@vumc.org
- Benoit Dawant, Ph.D. · Sub-investigator
- Hong Yu, MD · Sub-investigator
- Changqing Kao, MD, Ph.D. · Sub-investigator
- Dario Englot, MD, PhD · Sub-investigator
Recruiting
Study team
Sponsor
Vanderbilt University Medical Center
Study ID 060232
Principal investigator
Darioq j Englot, MD, Ph.D.
Vanderbilt University, Dept. Neurosurgery
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.